Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Concentrations of stiripentol in children and adults with epilepsy: the influence of dose, age, and comedication.

May TW, Boor R, Mayer T, Jürgens U, Rambeck B, Holert N, Korn-Merker E, Brandt C.

Ther Drug Monit. 2012 Aug;34(4):390-7. doi: 10.1097/FTD.0b013e31825dc4a6.

PMID:
22743350
2.

Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.

May TW, Boor R, Rambeck B, Jürgens U, Korn-Merker E, Brandt C.

Ther Drug Monit. 2011 Apr;33(2):214-21. doi: 10.1097/FTD.0b013e31820fa9ad.

PMID:
21383651
3.

Stiripentol: efficacy and tolerability in children with epilepsy.

Perez J, Chiron C, Musial C, Rey E, Blehaut H, d'Athis P, Vincent J, Dulac O.

Epilepsia. 1999 Nov;40(11):1618-26.

4.

Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication.

May TW, Rambeck B, Jürgens U.

Ther Drug Monit. 2002 Jun;24(3):366-74.

PMID:
12021627
6.
7.

Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication.

May TW, Rambeck B, Jürgens U.

Ther Drug Monit. 2003 Dec;25(6):690-9.

PMID:
14639055
8.

Serum concentrations of lamotrigine in epileptic patients: the influence of dose and comedication.

May TW, Rambeck B, Jürgens U.

Ther Drug Monit. 1996 Oct;18(5):523-31.

PMID:
8885114
9.

Stiripentol: an example of antiepileptic drug development in childhood epilepsies.

Nabbout R, Chiron C.

Eur J Paediatr Neurol. 2012 Sep;16 Suppl 1:S13-7. doi: 10.1016/j.ejpn.2012.04.009. Review.

PMID:
22695038
10.

Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication.

May TW, Rambeck B, Neb R, Jürgens U.

Ther Drug Monit. 2007 Dec;29(6):789-94.

PMID:
18043477
11.

Drug interaction and pharmacokinetic modeling of oxcarbazepine in korean patients with epilepsy.

Park KJ, Kim JR, Joo EY, Seo DW, Hong SB, Ko JW, Kim SR, Huh W, Lee SY.

Clin Neuropharmacol. 2012 Jan-Feb;35(1):40-4. doi: 10.1097/WNF.0b013e31824150a5.

PMID:
22246398
12.

Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.

Messina S, Battino D, Croci D, Mamoli D, Ratti S, Perucca E.

Epilepsia. 2005 Mar;46(3):372-7.

14.

Lacosamide serum concentrations in adult patients with epilepsy: the influence of gender, age, dose, and concomitant antiepileptic drugs.

Markoula S, Teotonio R, Ratnaraj N, Duncan JS, Sander JW, Patsalos PN.

Ther Drug Monit. 2014 Aug;36(4):494-8. doi: 10.1097/FTD.0000000000000051.

PMID:
24562047
15.

Does lamotrigine influence valproate concentrations?

Mataringa MI, May TW, Rambeck B.

Ther Drug Monit. 2002 Oct;24(5):631-6.

PMID:
12352935
16.

Serum concentrations of valproic acid: influence of dose and comedication.

May T, Rambeck B.

Ther Drug Monit. 1985;7(4):387-90.

PMID:
3936236
17.

Pharmacokinetics of clobazam and N-desmethylclobazam in children with dravet syndrome receiving concomitant stiripentol and valproic Acid.

Jullien V, Chhun S, Rey E, Dulac O, Tod M, Chiron C, Pons G.

Clin Pharmacokinet. 2015 May;54(5):527-36. doi: 10.1007/s40262-014-0223-5.

PMID:
25503589
18.

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.

Perucca E, Cloyd J, Critchley D, Fuseau E.

Epilepsia. 2008 Jul;49(7):1123-41. doi: 10.1111/j.1528-1167.2008.01665.x.

20.

Stiripentol.

Chiron C.

Expert Opin Investig Drugs. 2005 Jul;14(7):905-11. Review.

PMID:
16022579

Supplemental Content

Support Center